Ozempic Just Slowed Aging by 9% #longevity #antiaging
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →About this video
Creator description · original textText language: English
This week in longevity: a GLP-1 weight-loss drug (semaglutide) appears to have slowed biological aging by ~9% in a human trial — likely tied to visceral fat loss and reduced inflammation. Sam Altman-backed Retro Biosciences just hit a $1.8B valuation chasing 10 extra healthy years through cellular reprogramming, with its first human trial already underway. Follow for weekly evidence-based longevity news, and drop your questions below.
SOURCES:
Story 1
https://today.ucsd.edu/story/study-popular-glp-1-drug-may-slow-down-biological-aging
Story 2
https://www.statnews.com/2026/05/22/retro-biosciences-longevity-valuation/
Story 3
https://www.fightaging.org/archives/2026/06/a-liver-aging-clock-predicts-all-cause-mortality/
Bonus Story
https://www.fightaging.org/archives/2026/06/naked-mole-rats-exhibit-a-consistently-low-resting-metabolic-rate-with-aging/
Philipp Karner · 2 min · Source published: 2026-06-27
Added to Harbor: 10/29/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.